MWI Veterinary, Inc. Acquisition By AmerisourceBergen Corporation May Not Be In The Best Interest Of MWIV Shareholders
NEW YORK, Feb. 2, 2015 /PRNewswire/ -- The fairness of the proposed acquisition of MWI Veterinary, Inc. ("MWIV" or the "Company") by AmerisourceBergen Corporation ("AmerisourceBergen") is the subject of an investigation by WeissLaw LLP, a national class action, shareholder rights law firm. The investigation is focusing on possible breaches of fiduciary duty and other violations of law by the Board of Directors of MWIV for agreeing to sell the Company to AmerisourceBergen. On January 12, 2015, the Company announced it had reached a definitive agreement for AmerisourceBergen to acquire MWIV in a transaction valued at approximately $2.5 billion. Under the terms of the agreement, MWIV shareholders will receive $190.00 in cash for each MWIV share they own.
WeissLaw is investigating whether MWIV's Board acted to maximize shareholder value prior to entering into the agreement. Notably, the offer price represents a mere 7.9% premium over the Company's January 9, 2015 closing price. In addition, the Company recently announced strong quarterly earnings for the fourth quarter 2014, including total revenues of $794.1 million, a 31.2% increase over the fourth quarter 2013.
Given these facts, WeissLaw is investigating whether MWIV's Board acted in the best interests of MWIV's public shareholders by actively shopping the Company to maximize shareholder value prior to entering into the agreement with AmerisourceBergen. If you own MWIV shares and would like more information about your rights or our investigation, or if you have information to share with us, please contact Joshua Rubin or Kelly Keenan by telephone at (888) 593-4771 or by email at [email protected].
WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at [email protected] or fill out the form on our website, http://www.weisslawllp.com/contact/report_fraud/.
Attorney Advertising. Past results do not guarantee a similar outcome.
WeissLaw LLP
Joshua Rubin
Kelly Keenan
1500 Broadway, 16th Floor
New York, NY 10036
T: 212.682.3025
F: 212.682.3010
www.weisslawllp.com
[email protected]
SOURCE WeissLaw LLP
Share this article